While insulin resistance is a cardinal pathogenic feature of T2DM, affecting 90–95% of patients, diabetes does not occur until the pancreatic islet β‐cell no longer produces insulin in a rate sufficient to fully compensate for the impaired insulin sensitivity (Weir 1995). The gene discussed is INS; the disease is diabetes mellitus.